~~<i id='4D28AE6A0E'><strike id='4D28AE6A0E'><tt id='4D28AE6A0E'><pre id='4D28AE6A0E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：Wikipedia 2025-09-14 18:24:43 - browse：75

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Why you get paid to donate plasma but not blood

focus

hotspot

entertainment

hotspot

explore

LUCKNOW,India--FifteenpeopleincludingsixpolicerofficersdiedWednesdaybyelectrocutionafteratransformer

WSS

J&J to emphasize cancer drugs, stop much of its vaccine research

Study: Hearing aids may slow cognitive decline in those at risk

BIO selects John Crowley as new CEO

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Biden administration sends mixed signals on US soldier who crossed into North Korea

focus

leisure time

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

What we know about the American soldier detained in North Korea

Cancer drug shortages should be causing more outrage

30 years of 'Listening to Prozac'

In Memoriam: Notable people who died in 2023

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Dobbs anniversary: the lost opportunity of abortion as health care

Flagship Pioneering launches a new biotech in two countries

Moonlake's readout produced a cash windfall. Risks remain

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

hotspot

Flagship Pioneering launches a new biotech in two countries

FDA investigates CAR

What don’t we know about an Alzheimer’s drug side effect?

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Pediatric cancer treatments threatened by a new FDA policy

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

entertainment

hotspot

hotspot

explore